跳轉至內容
Merck
全部照片(1)

重要文件

SML0666

Sigma-Aldrich

GSK1210151A

≥98% (HPLC)

同義詞:

7-(3,5-二甲基-4-异噁唑基)-1,3-二氢-8-甲氧基-1-[(1R)-1-(2-吡啶基)乙基]-2H-咪唑并[4,5-C]喹啉-2-酮, I-BET151

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C23H21N5O3
CAS號碼:
分子量::
415.44
分類程式碼代碼:
12352200
NACRES:
NA.77
暫時無法取得訂價和供貨情況

化驗

≥98% (HPLC)

形狀

powder

顏色

white to beige

溶解度

DMSO: 20 mg/mL, clear

起源

GlaxoSmithKline

相關疾病

cancer

儲存溫度

2-8°C

SMILES 字串

[n]2(c3c([nH][c]2=O)cnc4c3cc(c(c4)c5c(n[o]c5C)C)OC)[C@H](C)c1ncccc1

InChI

1S/C23H21N5O3/c1-12-21(14(3)31-27-12)16-9-18-15(10-20(16)30-4)22-19(11-25-18)26-23(29)28(22)13(2)17-7-5-6-8-24-17/h5-11,13H,1-4H3,(H,26,29)/t13-/m1/s1

InChI 密鑰

VUVUVNZRUGEAHB-CYBMUJFWSA-N

應用

GSK1210151A 或 I-BET151 已用于研究其在治疗 MLL(混合谱系白血病)-融合性白血病中对 BET(溴结构域和额外末端)募集染色质的抑制作用。[1]

生化/生理作用

GSK1210151A(I-BET151)是 BET(溴结构域和额外末端域蛋白)家族的乙酰赖氨酸识别染色质 ′ 衔接子 ′ 蛋白抑制剂。
GSK1210151A(I-BET151)是 BET(溴结构域和额外末端域蛋白)家族的乙酰赖氨酸识别染色质 ′衔接子′ 蛋白抑制剂。GSK1210151A 取代了染色质的 BRD3 和 BRD4、PAFc 和 SEC 组份,从而抑制了参与混合谱系白血病(MLL)的关键基因(BCL2、C-MYC 和 CDK6)的转录。GSK1210151A(I-BET151)在 2 个 MLL 动物模型中显示出良好的疗效。

其他說明

化学探针门户网站已对 GSK1210151A 进行了专家评审和推荐。欲了解更多信息,请访问化学探针门户网站上的 GSK1210151A 探针摘要

象形圖

Skull and crossbones

訊號詞

Danger

危險聲明

危險分類

Acute Tox. 3 Oral

儲存類別代碼

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.
Shan X, et al.
eLife, 6, e25306-e25306 (2017)
Lisa-Maria Winter et al.
Scientific reports, 13(1), 12061-12061 (2023-07-27)
GDF15 has recently emerged as a key driver of the development of various disease conditions including cancer cachexia. Not only the tumor itself but also adverse effects of chemotherapy have been reported to contribute to increased GDF15. Although regulation of
Zhongyuan Gao et al.
Cancer biology & therapy, 19(5), 407-415 (2018-01-16)
Lung cancer is the leading cause of cancer-related death worldwide. Bromodomain and extraterminal domain (BET) proteins act as epigenome readers for gene transcriptional regulation. Among BET family members, BRD4 was well studied, but for its mechanism in non-small cell lung
Yan-Yi Jiang et al.
Gastroenterology, 159(4), 1311-1327 (2020-07-04)
We investigated the transcriptome of esophageal squamous cell carcinoma (ESCC) cells, activity of gene regulatory (enhancer and promoter regions), and the effects of blocking epigenetic regulatory proteins. We performed chromatin immunoprecipitation sequencing with antibodies against H3K4me1, H3K4me3, and H3K27ac and
Jun Li et al.
Cell reports, 37(11), 110124-110124 (2021-12-16)
Regulatory T (Treg) cells play crucial roles in suppressing deleterious immune response. Here, we investigate how Treg cells are mechanistically induced in vitro (iTreg) and stabilized via transcriptional regulation of Treg lineage-specifying factor Foxp3. We find that acetylation of histone tails

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務